ISRN Pediatrics

Volume 2012 (2012), Article ID 763783, 7 pages

doi:10.5402/2012/763783

Research Article

Screening for Celiac Disease in Children with Dental Enamel Defects

Mostafa Abdel-Aziz El-Hodhod,¹ Iman Ali El-Agouza,¹ Hala Abdel-Al,² Noha Samir Kabil,³ and Khaled Abd El-Moez Bayomi⁴

¹Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt

²Department of Clinical and Chemical Pathology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt

³Department of Orthodontic and Pediatric, Faculty of Dentistry, Ain Shams University, Cairo 11566, Egypt

⁴Ministry of Health, Cairo, Egypt

Received 21 March 2012; Accepted 17 April 2012

Academic Editors: M. S. Anderson and H. Neville

Copyright © 2012 Mostafa Abdel-Aziz El-Hodhod et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Dental enamel defects (DEDs) are seen in celiac disease (CD). Aim was to detect frequency of CD among such patients. Methods. This study included 140 children with DED. They were tested for CD. Gluten-free diet (GFD) was instituted for CD patients. A cohort of 720, age and sex-matched, normal children represented a control group. Both groups were evaluated clinically. Serum calcium, phosphorus, alkaline phosphatase, serum IgA, and tissue transglutaminase (tTG) IgG and IgA types were measured. Results. CD was more diagnosed in patients with DEDs (17.86%) compared to controls (0.97%) (). Majority of nonceliac patients showed grade 1 DED compared to grades 1, 2, and 3 DED in CD. Five children had DED of deciduous teeth and remaining in permanent ones. After 1 year on GFD, DED improved better in CD compared to nonceliac patients. Gastrointestinal symptoms did not vary between celiac and nonceliac DED patients. Lower serum calcium significantly predicted CD in this cohort. Conclusion. CD is more prevalent among children with DED than in the general population. These DEDs might be the only manifestation of CD; therefore, screening for CD is highly recommended among those patients especially in presence of underweight and hypocalcemia.

1. Introduction

Contrary to early beliefs, celiac disease (CD) is relatively common; however, it still remains underdiagnosed since most cases are atypical, with predominance of extra intestinal manifestations [1].

Available data showed that the prevalence of CD is around 1% of the general population [2]. However, almost 50% of the patients do not present with gastrointestinal symptoms [3]. Thus, in order to identify the greatest number of “atypical” or “silent” CD patients, it has been suggested that the clinicians should investigate those subjects who present with “indirect” signs of CD [4].

As abnormalities of the oral cavity have been reported in CD, clinical examination of the oral cavity can help to identify patients with atypical or silent CD [5, 6]. Specific features of the enamel hypoplasia were suggested as potential clinical markers of diagnosis of celiac disease in suspected cases [7]. Dental enamel defects (DEDs), mainly characterized by pitting, grooving, and sometimes by complete loss of enamel, were first reported in children with CD by Aine et al. [5]. These defects are considered specific to CD if they occur symmetrically and are chronologically distributed in all sections of permanent teeth [7].

Enamel mineralization disturbances secondary to CD do not occur before a period of gluten intake coinciding with enamel mineralization. A possible explanation for the enamel defects could be hypocalcemia or, more likely, a particular genetic condition that leads to a specific immune response to gluten [8]. In addition to hypocalcemia, other systemic factors are associated with enamel hypoplasia, such as malnutrition and vitamin D and A deficiency [9–11]. It is still not clear whether the oral lesions represent a direct manifestation of CD or whether they occur as a result of the indirect effects of malabsorption [12].

The aim of this work was to assess the frequency and predictors of CD among children with dental enamel defects as a step to decide whether these patients are candidates for routine celiac screening.

2. Methods

2.1. Study Population

This longitudinal clinical study was conducted in the General Pediatric Clinic, Dentistry Pediatric Clinic, and Pediatric Gastroenterology Unit, Children’s Hospital, Ain Shams University from May 2008 to April 2011.

The recruitment plan started with diagnosis of DED by the dentists in the general pediatric and pediatric dentistry clinics of Ain Shams University. They were referred to pediatric gastroenterology unit to complete the study provided they fulfilled the inclusion criteria and were free of the exclusion ones.

2.1.1. Inclusion Criteria

(1)Patients with DED.(2)Patents age between 4–12 years.

2.1.2. Exclusion Criteria

(1)Patients with chronic illness other than gastrointestinal symptoms.(2)Patients on inhalation therapy for bronchial asthma.

The study included 140 patients with DED defined and classified according to Aine et al. [5]. Their age ranged between 4–12 years. They were 72 males and 68 females. They were recruited among attendees of the general and dentistry pediatric clinics who showed any abnormality in teeth structure or shape (1482 children over a 3-year period).

A cohort of 720 healthy, age- (4–12 years), and sex- (371 males and 349 females) matched children was included as a control group. They were recruited among normal children coming for routine checkup in children’s hospital in the well child clinic.

2.2. Study Procedures

The study was approved by the local ethics committee of the Pediatrics Department, Faculty of Medicine, Ain Shams University. Informed consents were obtained from the legal guardians of the included subjects after explaining the nature of the study to them. This was done once DEDs were diagnosed. Children were subjected to full history taking with special emphasis on dietetic history, gastrointestinal symptoms, dental hygiene, and dentist visits. All included subjects underwent abdominal examination and anthropometric studies (weight and length) and evaluated on WHO growth curves [13].

Oral examination for hard tissue changes (i.e., DED) was done. Examination was carried out at the Pediatric Dentistry Department at Ain Shams Faculty of Dentistry by a pediatric dentist. Most of the patients did not need sedation. Only few patients (below the age of 6 years) required chloral hydrate sedation. In order to avoid masking of defects by dental plaque, teeth were cleaned with a toothbrush [14]. Teeth were carefully evaluated under good artificial light using dental mirrors, dental probes, and sterile gauze without excessive drying. Dental examination was performed in accordance with FDI criteria (modified DDE Index) [15]. The buccal, lingual, and occlusal surfaces were examined. A single defect measuring less than 1 mm in diameter was not recorded. In case of doubt about the existence of a defect, it was scored as normal. Opacities were differentiated from white spot carious lesions based on color, texture, demarcation, and relationship to gingival margin [14]. The enamel defects affecting deciduous and permanent teeth were graded 0 to IV according to Aine’s classification [5]. All patients were given full oral hygiene instructions after performing a complete dental prophylaxis. The candidates were followed up for oral hygiene and problematic defects were treated.

Laboratory assessment of celiac disease was based on the quantitative determination of antitissue transglutaminase IgA and IgG (anti-tTG IgA and anti-tTg IgG) using a sandwich Enzyme-Linked Immune-Sorbent Assay (ELISA) kit manufactured by Orgentec, Diagnostika GmbH, (Mainz, Germany). In this technique, anti-tTG IgA and anti-tTG IgG in the samples or standards bind to the microwells coated with human recombinant tTG IgA and tTG IgG. Horseradish peroxidase conjugated to tTG IgA and tTg IgG is added together with its substrate resulting in color development. The intensity of this color, which is proportional to the concentration of anti-tTG IgA and anti-tTg IgG, is measured photometrically at a wavelength of 450 nm. According to the manufacturer’s instructions a value above 10 U/mL was used as cutoff value to identify both anti-tTG IgA and anti-tTg IgG positivity.

Total serum IgA was measured, as well, by a radial immunodiffusion method (Diffu-Plate, Biocientífica, Buenos Aires, Argentina). Results were evaluated by using a reference table (routine determination). 5 mg/dL was used as cutoff value to identify IgA deficiency, in which a value below 5 mg/dL was considered to be IgA deficiency [16].

Positive serology (values ranged between 60–120 U/mL) patients (with either one or 2 positive antibodies) were subjected to esophagogastroduodenoscopy and intestinal biopsy from the second part of the duodenum (minimum of 4 biopsies) that were assessed histopathologically for features of celiac disease. The diagnosis of celiac cases was made according to Hill et al. [17]. Celiac patients were put on strict GFD and reassessed after 1 year.

Complete blood count was done on Cell-Dyn-1800 (Abbott Park Illinois, 100 Abbott Park road, 60064-3500 USA). Serum calcium, phosphorus and alkaline phosphatase was done on Synchron Cx9-Pro auto-analyzer (Beckmann instruments Inc. CA, USA).

3. Statistical Analysis

The results were collected, tabulated, and statistically analyzed using computer software: SPSS program for Windows, version 12.0.2. It included description of all qualitative variables in the form of frequency and percentage with comparison by test. Student -test was used to compare the quantitative variables. Logistic regression model was used to find out the most important independent predictors that could affect certain outcome.

4. Results

The study included 140 patients with DED. Their mean age was years. A group of 720 children free from any DEDs were recruited as controls. Their mean age was years. No statistical difference existed between patients and controls as regards age or gender () (), respectively. There was a significantly higher percentage of consanguinity among patients with DED (42.86%) compared to controls (23.47%) with .

Of the 140 patients with DEDs, 5 patients showed deciduous teeth abnormality, whereas 135 had the abnormalities in the permanent teeth. None of them showed mixed involvement. Gastrointestinal symptoms did not show statistical difference between patients and controls. However, underweight was significantly more encountered in patients with DEDs than controls (). Celiac disease was more commonly encountered among patients with DEDs compared to controls () (Table 1).

Table 1: Comparison of different variables between patients with dental enamel defects and controls.

Children with dental
Normal children (720)

enamel defects (140)

Males
72 (51.43%)
371 (51.53%)
0.001

Female
68 (48.57%)
349 (48.47%)

Consanguinity
60 (42.86%)
169 (23.47%)
17.71

No consanguinity
80 (57.14%)
551 (76.53%)

Recurrent GI symptoms
25 (17.86%)
146 (20.28%)
0.37

No
115 (82.14%)
574 (79.72)

Underweight
45 (32.14%)
41 (5.69%)
57.94

Not underweight
95 (67.86%)
679 (94.31%)

Celiac
25 (17.86%)
7 (0.97%)
36.95

Nonceliac
115 (82.14%)
713 (99.03%)

On comparing children with and without CD among DED patients, the mean weight and height among children with CD ( kg and  cm, resp.) were significantly lower than that of children without CD ( kg and  cm, resp.) with a in both.

There was a significantly lower mean calcium ( mg/dL) and phosphorous ( mg/dL) and a higher mean serum alkaline phosphatase ( IU/L) among cases compared to controls ( mg/dL,  mg/dL and  IU/L resp.) with for all.

No statistically significant difference was found between patients with CD and those without CD as regards gender. Although children with CD had high rates of vomiting, diarrhea, constipation, abdominal pain, and flatulence; these symptoms were not significantly different from those in non-CD patients. The most frequent symptom was abdominal pain (63.6% versus 48.0%), followed by flatulence and diarrhea (45.5% versus 18.0%), vomiting (27.3% versus 13.0%), and constipation (27.3% versus 11.0%) in the celiac and nonceliac children among the case group, respectively.

Consanguinity and underweight were more encountered in patients with CD compared to those without (Table 2). Moreover, underweight was more common in patients with CD more than controls (= 36.08 and ).

Table 2: Comparison between patients with dental enamel abnormalities who are positive for celiac disease versus those without celiac disease.

Dental enamel abnormalities
Dental enamel abnormalities

with celiac disease = 25
without celiac disease = 115

Males
15 (60%)
60 (52.17%)
0.51

Female
10 (40%)
55 (47.83%)

Consanguinity
16 (64%)
44 (38.26%)
5.56

No consanguinity
9 (36%)
71 (61.74%)

Recurrent GI symptoms
5 (20%)
20 (17.39%)
0.10

No
20 (80%)
95 (82.61%)

Underweight
15 (60%)
30 (26.09%)
10.83

Not underweight
10 (40%)
85 (73.91%)

There were significantly lower mean serum calcium and higher serum alkaline phosphatase among cases with CD ( mg/dL and  IU/L, resp.) compared to nonceliacs ( mg/dL and  IU/L, resp.), ( and , resp.). On the contrary, mean serum phosphorus was not statistically different between CD patients and nonceliacs ( mg/dL and  mg/dL, resp.).

After 1-year followup with routine dental care for all patients in addition to GFD in CD, the frequency of improvement of DED was significantly higher in CD compared to non-CD patients (). Grade 1 pathology was more seen in nonceliac compared to celiac both at start and after 1 year of care ( and , resp.). Grade 2 and 3 pathology were significantly more frequent in CD more than nonceliac patients at the start of study ( and , resp.). However, the difference became insignificant after 1 year of care. Frequency of grade 4 was not different between celiac and nonceliac patients. Moreover, grade 1 was not different in same group before and after 1 year of care (Table 3). Figure 1 showed that the degree of improvement of grade of DED in celiac patients was significantly higher than that of nonceliac patients. The maximum shift of DED grade was one level. Deciduous teeth showed no improvement at all.

Table 3: Grading of dental enamel pathology in patients according to celiac positivity and effect of a GFD for 1 year.

Celiac + DED at
Celiac + DED After
Nonceliac + DED at
Nonceliac + DED
GIa versus GIIa
GIb versus GIIb

start of study
1 year on GFD
start of study
after 1 year

(25)
(25)
(115)
(115)

(GIa)
(GIb)
(GIIa)
(GIIb)

Normal
0
6 (24%)
0
4 (3.48%)

Grade 1
7 (28%)
7 (28%)
80 (69.57%)
78(67.38%)

and
and

Grade 2
10 (40%)
6 (24%)
22 (19.13%)
21 (18.26%)

and
and

Grade 3
6 (24%)
4(16%)
11 (9.57%)
10 (8.7%)

and
and

Grade 4
2 (8%)
2 (8%)
2 (1.74%)
2 (1.74%)

and
and

Figure 1: Comparison between the degrees of improvement of grade of DED in patients with CD versus patients with non-CD. (DIFF_CD: degree of improvement in CD, DIFNONCD: degree of improvement in non-CD).

With regression analysis (at and ), age of patients and hypocalcemia were the only significant determinants ( and 0.026, resp.) of the diagnosis of CD among patients with DED, as seen in Table 4.

Table 4: regression summary for possible predictors of celiac disease in patients with DED.

Item
BETA
Standard error of BETA

Standard error of

Age
−0.344
0.117
−0.074
0.025
−2.947
0.005

Consanguinity
−0.191
0.264
−0.090
0.123
−0.725
0.471

Diarrhea
0.158
0.277
0.129
0.227
0.570
0.571

Abdominal distension
−0.040
0.144
−0.032
0.114
−0.277
0.783

Z score for weight
−0.120
0.121
−0.020
0.012
−1.658
0.104

Grade of enamel defects
0.049
0.207
0.043
0.181
0.235
0.815

Dental plaque
−0.209
0.203
−0.170
0.166
−1.026
0.310

Hemoglobin
−0.295
0.305
−0.085
0.088
−0.965
0.339

Calcium level
−0.524
0.228
−0.232
0.101
−2.293
0.026

, , Adjusted ,,1, Standard Error of estimate = 0.26854.

5. Discussion

Previous studies focused on description of DED in CD. In fact, this will not reflect how much common is CD among patients presenting with DEDs. In the current study, CD was the underlying cause of DEDs in 17.86% of the studied patients compared to 0.97% of normal children without DEDs. This high frequency justifies consideration of DED patients as candidates for screening for CD. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) included the presence of specific dental enamel defects as a risk factor for CD [17]. The same was recommended by Aine et al. and Petrecca et al. [5, 6].

Avşar and Kalayci [18] reported that the prevalence of DED in CD subjects was significantly higher (42.2%) than in healthy subjects (9.4%) (). Grade 1 type enamel defects were most commonly diagnosed in both groups (20.3% and 6.3%, resp.).

Wiernik et al. [19] found that 55% celiac patients had DED against 18% control subjects. Similarly, Páez et al. [20] detected DED in 83.3% of the celiac children versus 53.3% of the controls. On the other hand, Procaccini et al. [21] found that the prevalence of enamel hypoplasia was not higher in the study population than in the control group.

The prevalence of CD in normal children in this cohort was 0.97%, which was a little bit higher than Abu-Zekry et al. [22], who reported a frequency of 0.53 in Egyptian children. The frequency is near to most of western reports (around 1%) [23, 24] and lower than an African report (around 5%) [25].

In our study, grades 1, 2, and 3 of DED are more common than grade 4 pathology. Grades 2 and 3 are more common in CD than nonceliac. Improvement of grades, up to normalization of some cases, was significantly more achieved in CD than nonceliac patients who were maintained on routine dental care. The better improvement can be either attributed to direct effect of GFD on enamel or to improved nutritional status after such a regimen.

Ciacci et al. [26], reported that DEDs were found in 15 patients of transient GFD, 43 of never on GFD and zero of the GFD group.

The high mean age of CD patients was in agreement of Kuloğlu et al. [27] who reported that the age of children with classical type ( years) was significantly lower than the age of children with atypical form ( years). Other studies [28–31] reported a changing pattern in the presentation of pediatric CD towards more predominance of atypical presentations of CD and older age at diagnosis.

The Celiac Disease Guideline Committee of the NASPGHAN recommended that children and adolescents with symptoms of celiac disease or an increased risk for celiac disease should have a blood test for antibody to tissue transglutaminase, then those with an elevated TTG be referred for an intestinal biopsy to confirm the diagnosis [23].

Serum IgA is routinely measured to avoid bias of false-negative tTG IgA type. In our study, there was no difference between children with and without CD as regards serum total IgA level. According to many studies [32–35], selective IgA deficiency should be considered during screening for CD especially with TTG IgA. TTG antibody is recommended as a screening test for CD by many authors [24, 36–38].

In our study, consanguinity is evident in 60 children among cases with dental enamel defects (42.86%), while in controls it was 169 (23.47%) with a . Moreover, consanguinity was significantly more encountered in patients with CD (64%) compared to those without celiac pathology (38.26%). It is noticeable that patients with DED without CD still shows significant higher frequency of consanguinity compared to those without DED ( and ). This reflects already high consanguinity rates among normal Egyptian population. It also reflects that a genetic factor may be working in patients with DED with or without CD.

In patients with CD, serum calcium was significantly lower and serum alkaline phosphatase was significantly higher compared to those without CD. Moreover, serum calcium was the most important predictor of celiac pathology in patients with DED as shown by regression analysis.

Compared with controls, Praticò et al. [39] stated that celiac patients show at diagnosis a significant increase of serum phosphate and a decrease of calcium level. The authors concluded that CD affects clearly mineral metabolism. Actually, the tendency to hypocalcemia may be attributed to abnormalities of the intestinal mucosa. Similarly, Zanchi et al. [40] reported that calcium and the 25(OH) vitamin D3 levels were lower in children with CD than in control subjects, and the parathyroid hormone level was higher in children with CD than in control subjects.

In the current study, weight and height were significantly lower in CD patients compared to nonceliac ones. Many studies [27, 41, 42] found that weight and height were below the 3rd percentile in studied CD children.

In the present study, celiac patients with DEDs had high rates of vomiting, diarrhea, constipation, abdominal pain, and flatulence but difference from nonceliac patients was not significant. Similar to our results, Rashid et al. [38] found that the most frequent symptom was abdominal pain (90.0%) followed by diarrhea (65.0%), vomiting (53.0%), and constipation (30.0%). In contrast to the above-mentioned results, Kuloğlu et al. [27] reported that the most frequent symptom was diarrhea (53.2%) followed by failure to thrive (45.9%), short stature (42.2%), abdominal pain (40.4%), abdominal distention (26.6%), fatigue (27.5%), pallor (23.9%), and vomiting (12.8%).

The variable results reported concerning the frequency of symptoms of CD can be explained by the wide spectrum of classical and nonclassical presentations of CD. Also, the difference in population homogeneity, environmental, dietary, and genetic factors may explain the variable results in each study. However, many studies reported that abdominal pain and diarrhea are the most frequent symptoms in classical CD.

The lack of predictive value of the gastrointestinal manifestations to pick up CD among DED patients is of utmost importance. It is, with the high frequency of CD in this context, a good evidence for a true need for celiac screening among DED patients.

We can conclude that the prevalence of CD, among children with dental enamel defects, is much higher than in the general population. These enamel problems might be the only manifestation of celiac disease. So, screening for CD is highly recommended among those patients especially in presence of underweight and hypocalcemia.

What is known?

Dental enamel defects are common among celiac compared to nonceliac children.

What is not known?

To take a look at the other face of the coin, what is the magnitude of CD among patients with dental enamel defects? In other words, is CD common enough in this sector of patients to deserve routine screening?

Conflict of Interests

The authors declare that there is no conflict of interest with any authority related the subject of the study.

Disclaimer

Mostafa El-Hodhod, the Principal Investigator, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

References

L. Pastore, A. Carroccio, D. Compilato, V. Panzarella, R. Serpico, and L. L. Muzio, “Oral manifestations of Celiac disease,” Journal of Clinical Gastroenterology, vol. 42, no. 3, pp. 224–232, 2008.

A. Tommasini, T. Not, V. Kiren et al., “Mass screening for coeliac disease using antihuman transglutaminase antibody assay,” Archives of Disease in Childhood, vol. 89, no. 6, pp. 512–515, 2004.

A. Carroccio, E. Iannitto, F. Cavataio et al., “Sideropenic anemia and Celiac disease: one study, two points of view,” Digestive Diseases and Sciences, vol. 43, no. 3, pp. 673–678, 1998.

P. Bucci, F. Carile, A. Sangianantoni, F. D'Angiò, A. Santarelli, and L. L. Muzio, “Oral aphthous ulcers and dental enamel defects in children with coeliac disease,” Acta Paediatrica, vol. 95, no. 2, pp. 203–207, 2006.

L. Aine, M. Maki, O. Keyrilainen, and P. Collin, “Dental enamel defects in Celiac disease,” Journal of Oral Pathology and Medicine, vol. 19, no. 6, pp. 241–245, 1990.

S. Petrecca, G. Giammaria, and A. F. Giammaria, “Oral cavity changes in the child with Celiac disease,” Minerva Stomatologica, vol. 43, no. 4, pp. 137–140, 1994.

M. Bossù, A. Bartoli, G. Orsini, E. Luppino, and A. Polimeni, “Enamel hypoplasia in coeliac children: a potential clinical marker of early diagnosis,” European Journal of Paediatric Dentistry, vol. 8, no. 1, pp. 31–37, 2007.

J. M. Aguirre, R. Rodríguez, D. Oribe, and J. C. Vitoria, “Dental enamel defects in Celiac patients,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 84, no. 6, pp. 646–650, 1997.

M. Maki, L. Aine, V. Lipsanen, and S. Koskimies, “Dental enamel defects in first-degree relatives of coeliac disease patients,” The Lancet, vol. 337, no. 8744, pp. 763–764, 1991.

M. Mäki, S. Sulkanen, and P. Collin, “Antibodies in relation to gluten intake,” Digestive Diseases, vol. 16, no. 6, pp. 330–332, 1998.

W. K. Seow, “Enamel hypoplasia in the primary dentition: a review,” ASDC Journal of Dentistry for Children, vol. 58, no. 6, pp. 441–452, 1991.

L. Abenavoli, L. Proietti, L. Leggio et al., “Cutaneous manifestations in Celiac disease,” World Journal of Gastroenterology, vol. 12, no. 6, pp. 843–852, 2006.

WHO Multicentre Growth Reference Study Group, “WHO child growth standards based on length/height, weight and age,” Acta Paediatrica. Supplement, vol. 450, pp. 76–85, 2006.

W. K. Seow, “Clinical diagnosis of enamel defects: pitfalls and practical guidelines,” International Dental Journal, vol. 47, no. 3, pp. 173–182, 1997.

FDI Commission on Oral Health, “Research and epidemiology: a review of the developmental defects of enamel index (DDE index),” International Dental Journal, vol. 42, pp. 411–426, 1992.

L. F. Pereira, A. M. Sapina, J. Arroyo, J. Vinuelas, R. M. Bardaji, and L. Prieto, “Prevalence of selective IgA deficiency in Spain: more than we thought,” Blood, vol. 90, no. 2, article 893, 1997.

I. D. Hill, M. H. Dirks, G. S. Liptak et al., “Guideline for the diagnosis and treatment of Celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition,” Journal of Pediatric Gastroenterology and Nutrition, vol. 40, no. 1, pp. 1–19, 2005.

A. Avşar and A. G. Kalayci, “The presence and distribution of dental enamel defects and caries in children with Celiac disease,” Turkish Journal of Pediatrics, vol. 50, no. 1, pp. 45–50, 2008.

C. D. Wierink, D. E. van Diermen, I. H. A. Aartman, and H. S. A. Heymans, “Dental enamel defects in children with coeliac disease,” International Journal of Paediatric Dentistry, vol. 17, no. 3, pp. 163–168, 2007.

E. O. Páez, P. J. Lafuente, P. B. García, J. M. Lozano, and J. C. L. Calvo, “Prevalence of dental enamel defects in Celiac patients with deciduous dentition: a pilot study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 106, no. 1, pp. 74–78, 2008.

M. Procaccini, G. Campisi, P. Bufo et al., “Lack of association between Celiac disease and dental enamel hypoplasia in a case-control study from an Italian central region,” Head and Face Medicine, vol. 3, no. 1, article 25, 2007.

M. Abu-Zekry, D. Kryszak, M. Diab, C. Catassi, and A. Fasano, “Prevalence of Celiac disease in egyptian children disputes the east west agriculture-dependent spread of the disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 47, no. 2, pp. 136–140, 2008.

A. Fasano, I. Berti, T. Gerarduzzi et al., “Prevalence of Celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study,” Archives of Internal Medicine, vol. 163, no. 3, pp. 286–292, 2003.

M. Mäki, K. Mustalahti, J. Kokkonen et al., “Prevalence of Celiac disease among children in Finland,” The New England Journal of Medicine, vol. 348, no. 25, pp. 2517–2524, 2003.

C. Catassi, I. M. Rätsch, L. Gandolfi et al., “Why is coeliac disease endemic in the people of the Sahara?” The Lancet, vol. 354, no. 9179, pp. 647–648, 1999.

C. Ciacci, P. Iovino, D. Amoruso et al., “Grown-up coeliac children: the effects of only a few years on a gluten-free diet in childhood,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 4, pp. 421–429, 2005.

Z. Kuloǧlu, C. T. Kirsaçlioǧlu, A. Kansu, A. Ensari, and N. Girgin, “Celiac disease: presentation of 109 children,” Yonsei Medical Journal, vol. 50, no. 5, pp. 617–623, 2009.

G. Dinler, E. Atalay, and A. G. KalaycI, “Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey,” World Journal of Pediatrics, vol. 5, no. 4, pp. 282–286, 2009.

W. Holtmeier, J. Henker, E. O. Riecken, and K. P. Zimmer, “Definitions of Celiac disease—statement of an expert group from the German society for Celiac disease,” Zeitschrift fur Gastroenterologie, vol. 43, no. 8, pp. 751–754, 2005.

C. H. Priovolou, A. P. Vanderas, and L. Papagiannoulis, “A comparative study on the prevalence of enamel defects and dental caries in children and adolescents with and without coeliac disease,” European Journal of Paediatric Dentistry, vol. 5, no. 2, pp. 102–106, 2004.

E. Roma, J. Panayiotou, H. Karantana et al., “Changing pattern in the clinical presentation of pediatric Celiac disease: a 30-year study,” Digestion, vol. 80, no. 3, pp. 185–191, 2009.

F. Cataldo, V. Marino, G. Bottaro, P. Greco, and A. Ventura, “Celiac disease and selective immunoglobulin A deficiency,” Journal of Pediatrics, vol. 131, no. 2, pp. 306–308, 1997.

V. Kumar, M. Jarzabek-Chorzelska, J. Sulej, K. Karnewska, T. Farrell, and S. Jablonska, “Celiac disease and immunoglobulin A deficiency: how effective are the serological methods of diagnosis?” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 6, pp. 1295–1300, 2002.

K. E. McGowan, M. E. Lyon, and J. D. Butzner, “Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic,” Clinical Chemistry, vol. 54, no. 7, pp. 1203–1209, 2008.

H. E. Prince, G. L. Norman, and W. L. Binder, “Immunoglobulin A (IgA) deficiency and alternative Celiac disease- associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 2, pp. 192–196, 2000.

C. C. Barker, C. Mitton, G. Jevon, and T. Mock, “Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose Celiac disease in select pediatric populations?” Pediatrics, vol. 115, no. 5, pp. 1341–1346, 2005.

A. W. Chan, J. D. Butzner, R. McKenna, and M. J. Fritzler, “Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for Celiac disease in pediatric patients,” Pediatrics, vol. 107, no. 1, article E8, 2001.

M. Rashid, A. Cranney, M. Zarkadas et al., “Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children,” Pediatrics, vol. 116, no. 6, pp. e754–e759, 2005.

G. Praticò, L. Caltabiano, G. Bottaro, G. M. Palano, N. Rotolo, and M. Spina, “Calcium-phosphorus metabolism in Celiac disease in children,” La Pediatria Medica e Chirurgica, vol. 17, no. 5, pp. 403–406, 1995.

C. Zanchi, G. Di Leo, L. Ronfani, S. Martelossi, T. Not, and A. Ventura, “Bone metabolism in Celiac disease,” Journal of Pediatrics, vol. 153, no. 2, pp. 262–265, 2008.

G. Barera, S. Mora, P. Brambilla et al., “Body composition in children with Celiac disease and the effects of a gluten-free diet: a prospective case-control study,” American Journal of Clinical Nutrition, vol. 72, no. 1, pp. 71–75, 2000.

G. M. Damen, B. Boersma, J. M. Wit, and H. S. A. Heymans, “Catch-up growth in 60 children with Celiac disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 19, no. 4, pp. 394–400, 1994.